• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by SHL Telemedicine Ltd

    9/26/24 8:36:19 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care
    Get the next $SHLT alert in real time by email
    SHL TELEMEDICINE LTD - 1166834 - 2024
    0001166834Q2false--12-31

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington D.C. 20549
     
    Form 6-K
     
    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    For the month of September 2024
    Commission File Number: 001-41641

    SHL TELEMEDICINE LTD.
    (Translation of registrant’s name into English)
     
    90 Yigal Alon Street
    Tel Aviv 67891, Israel
    (Address of principal executive offices)
     
    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
     
    Form 20-F ☒             Form 40-F ☐
     

     
    EXPLANATORY NOTE
     
    On September 26, 2024, SHL Telemedicine Ltd. (the “Company”) issued a press release, an investor presentation and a report with respect to its half-year 2024 financial results, copies of which are furnished herewith as Exhibits 99.1, 99.2 and 99.3, respectively, and which are incorporated by reference herein. The press release, investor presentation and report all contain forward-looking statements and include cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements.
     
    On September 26, 2024, the Company also published unaudited interim condensed consolidated financial statements as of and for the six months ended June 30, 2024, a copy of which is furnished herewith as Exhibit 99.4 and which is incorporated by reference herein. The financial statements are formatted in Inline eXtensible Business Reporting Language (“iXBRL”) as Exhibit 101 in accordance with Rule 405 of Regulation S-T and paragraph C.(6)(a)(ii) of the General Instructions to Form 6-K.
     
    This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).
     

     
    Exhibit 
     Description
     
    99.1
    Press release, dated September 26, 2024, with respect to half-year 2024 financial results.
    99.2
    Investor Presentation issued on September 26, 2024, with respect to half-year 2024 financial results.
    99.3
    Report with respect to half-year 2024 financial results.
    99.4
    Unaudited interim condensed consolidated financial statements as of and for the six months ended June 30, 2024.
     
    101.INS
    Inline XBRL Instance Document.
    101.SCH
    Inline XBRL Taxonomy Extension Schema Document.
    101.CAL
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.
    101.DEF
    Inline XBRL Taxonomy Extension Definition Linkbase.
    101.LAB
    Inline XBRL Taxonomy Extension Label Linkbase.
    101.PRE
    Inline XBRL Taxonomy Extension Presentation Linkbase.
     

     
    SIGNATURE
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
     
     
    SHL Telemedicine Ltd.
     
    By: /s/ Amir Hai
          Amir Hai
          Chief Financial Officer
     
    September 26, 2024

     


    Get the next $SHLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SHLT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SHLT
    Leadership Updates

    Live Leadership Updates

    View All

    SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine

    David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two of the largest insurance groups in Israel SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX: SHLTN, ))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has announced today that it has appointed Mr. David Arnon as CEO of the Company. He will join SHL Telemedicine and assume the role on August 6, 2024, succeeding Erez Nachtomy, who, as previously announced, will step down as CEO. Mr. Arnon has over 17 years of commercial and executive level management experience within the healthcare insurance industry in Israel.

    7/29/24 4:30:00 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    $SHLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by SHL Telemedicine Ltd

    SC 13G - SHL TELEMEDICINE LTD (0001166834) (Subject)

    11/13/24 6:16:50 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by SHL Telemedicine Ltd

    SC 13G - SHL TELEMEDICINE LTD (0001166834) (Subject)

    7/24/24 12:18:01 PM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    $SHLT
    SEC Filings

    View All

    SEC Form 6-K filed by SHL Telemedicine Ltd

    6-K - SHL TELEMEDICINE LTD (0001166834) (Filer)

    4/24/25 4:12:53 PM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by SHL Telemedicine Ltd

    6-K - SHL TELEMEDICINE LTD (0001166834) (Filer)

    4/22/25 4:05:08 PM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by SHL Telemedicine Ltd

    6-K - SHL TELEMEDICINE LTD (0001166834) (Filer)

    4/3/25 4:13:21 PM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    $SHLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced an expanded partnership with SHL Telemedicine (NASDAQ:SHLT) to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. This expanded collaboration, initially launched in the New York-New Jersey area, will now bring advanced cardiovascular diagnostics to patients' homes and underserved communities in additional markets across the country. According to the Journal of the American College of Cardiology, 46% of U.S. counties do not have any cardiologists1, highlighting the urgent need for accessible cardiovascular care. SHL

    12/18/24 7:35:00 AM ET
    $DCGO
    $SHLT
    Medical/Nursing Services
    Health Care

    SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine

    David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two of the largest insurance groups in Israel SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX: SHLTN, ))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has announced today that it has appointed Mr. David Arnon as CEO of the Company. He will join SHL Telemedicine and assume the role on August 6, 2024, succeeding Erez Nachtomy, who, as previously announced, will step down as CEO. Mr. Arnon has over 17 years of commercial and executive level management experience within the healthcare insurance industry in Israel.

    7/29/24 4:30:00 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity

    SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX: SHLTN, ))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has clarified today that it is in discussions with Discount Capital Ltd. the investment arm of Israel Discount Bank, regarding a possible investment relating to SHL's Israeli activity. At this point, the parties have not yet taken any decision nor entered into any binding obligation with regard to the realization of such transaction. SHL will further inform the market as required. About SHL Telemedicine SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center service

    6/20/24 6:32:00 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    $SHLT
    Financials

    Live finance-specific insights

    View All

    SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

    SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX Swiss Exchange: SHLTN))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus on expansion and innovation. In 2023, SHL Telemedicine achieved key highlights, underscoring its global market strength. SHL's Israel operation maintained stability and profitability, reflecting the company's solid foundation in its home market. In the US, significant advancements were made toward launching direct-to-consumer (B2C) sales of the SmartHeart® ECG platform, enhancing access to r

    4/17/24 5:00:00 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023

    SHL Telemedicine Ltd. ((SIX Swiss Exchange: SHLTN, NASDAQ:SHLT) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will publish its results for 2023 on Wednesday, April 17, 2024 at 7 am CET. The conference call for investors, journalists, and analysts to discuss the annual results 2023 will be hosted by Yariv Alroy, Chairman, Erez Nachtomy, CEO, and Amir Hai, CFO, and has been scheduled for the same day as following: Date: Wednesday, April 17, 2024 Time: 4 pm CET / 10 am ET / 5 pm Israel Time The conference call can be accessed live via the below dial-in numbers: From Europe   +41 (0) 58 310 5

    4/5/24 2:30:00 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care

    SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth

    Regulatory News: SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX Swiss Exchange: SHLTN))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for half-year 2023, emphasizing stable revenues and strategic growth initiatives. In H1 2023, SHL maintained stable revenues while making significant strategic advancements across all operations. The Company made substantial investments in Germany, where it launched the Doctors' Virtual Visits services and then witnessed a steady increase in the adoption of the service. In the US, the Company witnessed the growing utilization and distribution of the SmartHeart® ECG platform by

    9/21/23 7:54:00 AM ET
    $SHLT
    Medical/Nursing Services
    Health Care